Skip to main content
Log in

Adjuvant radiotherapy of no value in endometrial cancer?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Calloway Rankins N, Alvarez Secord A, Jewell E, Havrilesky LJ, Soper JT, Myers E.Cost-effectiveness of adjuvant radiotherapy in intermedite risk endometrial cancer. Gynecologic Oncology 106: 388-393, No. 2, Aug 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adjuvant radiotherapy of no value in endometrial cancer?. Pharmacoecon. Outcomes News 538, 9 (2007). https://doi.org/10.2165/00151234-200705380-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705380-00019

Keywords

Navigation